Biogen Idec Inc. (BIIB)
-NasdaqGS 217.30 
2.97(1.39%) 4:00PM EDT|After Hours
:
217.68 0.38 (0.18%) 4:42PM EDT
| Prev Close: | 214.33 |
|---|
| Open: | 214.91 |
|---|
| Bid: | 200.00 x 100 |
|---|
| Ask: | 224.90 x 100 |
|---|
| 1y Target Est: | 205.40 |
|---|
| Beta: | 1.29 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 213.26 - 219.08 |
|---|
| 52wk Range: | 126.39 - 226.18 |
|---|
| Volume: | 1,124,451 |
|---|
| Avg Vol (3m): | 1,398,260 |
|---|
| Market Cap: | 51.58B |
|---|
| P/E (ttm): | 34.48 |
|---|
| EPS (ttm): | 6.30 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Top Fund Buys Focus On Defensive Stocks, Housingat Investor's Business Daily(Thu 5:45PM EDT)
- UPDATE 1-Elan considered buying Royalty before becoming its targetat Reuters(Thu 12:55PM EDT)
- Texas Instruments Senior VP Sells 88K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Thu 9:10AM EDT)
- Royalty Pharma stands by reduced Elan bidat Reuters(Thu 8:42AM EDT)
- 3 Healthcare Stock Stories For Midweek Wellnessat Wall St. Cheat Sheet(Thu 8:34AM EDT)
- 3 Investment Ideas for Biotech Investorsat Motley Fool(Wed, May 1)
- Intel Gets Booed and 4 More Analyst Downgrades To Knowat Wall St. Cheat Sheet(Wed, May 1)
- BIOGEN IDEC INC. FinancialsEDGAR Online Financials(Wed, May 1)
- Fidelity Contrafund's Danoff frets over Apple rivalsReuters(Wed, May 1)
- UPDATE 2-Fidelity Contrafund's Danoff frets over Apple rivalsat Reuters(Wed, May 1)
- Finding Innovation in Biotechnology for Cell Therapy, Oncology and Orphan Drugs: A Wall Street Transcript Interview with Boris Peaker, Executive Director and Senior Analyst at Oppenheimer & Co. Inc.Wall Street Transcript(Wed, May 1)
- On The Fly: Analyst Downgrade Summaryat theflyonthewall.com(Wed, May 1)
- Analyst Moves: BIIB, X, PFEat Forbes(Wed, May 1)
- 3 Stocks to Get on Your Watchlistat Motley Fool(Wed, May 1)
- Stock Downgrades: Sky Falls in on Cloud Peak Energyat Minyanville(Wed, May 1)
Key Statistics
| Forward P/E (1 yr): | 22.26 |
|---|
| P/S (ttm): | 9.02 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 7.83 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.86 |
|---|
| Mean Recommendation*: | 2.1 |
|---|
| PEG Ratio (5 yr expected): | 1.50 |
|---|
Business Summary
Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally.
View More